Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement,... see more

GREY:CBICF - Post Discussion

The Canadian Bioceutical > Number of IAN shares MPX shareholders will get
View:
Post by akstock on Oct 20, 2018 3:42pm

Number of IAN shares MPX shareholders will get

I just watched again the Midas Letter interview of Scott Boyes (CEO of MPX) regarding the IAN / MPX merger

Link: https://www.youtube.com/watch?v=yWWWJMgupRg

Excuse me if it was mentioned somewhere else, but something completely new caught my ears.

At 53:00, James West asked Scott how many shares will MPX end up holding of iAnthus.

Scott mentions the ratio but then conclude by saying "the number of shares will depend on the share price of iAnthus at time of close"

What I conclude from that is they will adjust the # of IAN shares MPX holders will receive to respect the 30.6% premium announced. This way, it protects both companies in the case IAN share price at time of closing would be too low (making MPX sell their company at a lower price) or too high (making IAN buy MPX at an higher price).

Let me know what you think. Before seeing that, I always felt something was wrong about that deal due to the fact that the SP can fluctuate so much by January 2019.

Please correct me if I am wrong and let me know what you think of this and what should be the best strategy to play until the deal closes.

Comment by Kmd001 on Oct 20, 2018 9:23pm
No, that's incorrect.  Individual holders will receive .1673 shares of IAN for each MPX share they hold. That will not change. 
Comment by akstock on Oct 21, 2018 1:45am
No, that might be correct. Go watch the video. I transcripted what the CEO of MPX is saying. Doesn't he know his own deal? I emailed both IR.
Comment by Kmd001 on Oct 21, 2018 7:21am
He's not talking about the number of IAN shares an individual MPX holder gets in return for their MPX shares.  Read the press release ffs.
Comment by Kmd001 on Oct 21, 2018 7:37am
Better yet-  read the Sedar filings and listen to the conference call,. The exchange ratio is fixed. The exchange ratio is not changing based on stock price movement. The exchange ratio is .1673 shares of iAnthus for every MPX share, plus you get MPXI. If you think some comment you are misintepreting on some youtube video is more impactful than a Sedar filing or a conference call with the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities